Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-115695

Options or other derivatives

  • Chief Operating Officer acquired 18,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bruno Julianne · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-16 Grant or award : show line 1 in the form Stock Option (Right to Buy) +18,333 18,333 D
Loading xslF345X05/ownership.xml…